101 related articles for article (PubMed ID: 30327581)
1. Photochemical Treatment of
Ye J; Yang C; Cai Z; Shi W; Yu H
Mediators Inflamm; 2018; 2018():4167652. PubMed ID: 30327581
[No Abstract] [Full Text] [Related]
2. Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy.
Yiwen Z; Shilin G; Yingshi C; Lishi S; Baohong L; Chao L; Linghua L; Ting P; Hui Z
Oncotarget; 2016 Nov; 7(47):77732-77748. PubMed ID: 27780916
[TBL] [Abstract][Full Text] [Related]
3. Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.
Yang S; Tsang KY; Schlom J
Clin Cancer Res; 2005 Aug; 11(15):5603-15. PubMed ID: 16061879
[TBL] [Abstract][Full Text] [Related]
4. Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to Immunotherapy.
Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Morisaki T; Goto M; Iwama M; Akaike T; Hasumi K
Anticancer Res; 2016 Feb; 36(2):673-6. PubMed ID: 26851023
[TBL] [Abstract][Full Text] [Related]
5. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
6. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
7. Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.
Sun L; Guo H; Jiang R; Lu L; Liu T; Zhang Z; He X
Oncotarget; 2016 Apr; 7(14):17579-90. PubMed ID: 27007051
[TBL] [Abstract][Full Text] [Related]
8. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Dupont J; Latouche JB; Ma C; Sadelain M
Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
[TBL] [Abstract][Full Text] [Related]
9. Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules.
Zajac P; Schütz A; Oertli D; Noppen C; Schaefer C; Heberer M; Spagnoli GC; Marti WR
Cancer Res; 1998 Oct; 58(20):4567-71. PubMed ID: 9788602
[TBL] [Abstract][Full Text] [Related]
10. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
Chang J
Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
[TBL] [Abstract][Full Text] [Related]
11. Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Rudolf D; Silberzahn T; Walter S; Maurer D; Engelhard J; Wernet D; Bühring HJ; Jung G; Kwon BS; Rammensee HG; Stevanović S
Cancer Immunol Immunother; 2008 Feb; 57(2):175-83. PubMed ID: 17657490
[TBL] [Abstract][Full Text] [Related]
12. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
13. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
Sigal LJ; Reiser H; Rock KL
J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
[TBL] [Abstract][Full Text] [Related]
14. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
15. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
16. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
Butler MO; Lee JS; Ansén S; Neuberg D; Hodi FS; Murray AP; Drury L; Berezovskaya A; Mulligan RC; Nadler LM; Hirano N
Clin Cancer Res; 2007 Mar; 13(6):1857-67. PubMed ID: 17363542
[TBL] [Abstract][Full Text] [Related]
17. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
[TBL] [Abstract][Full Text] [Related]
18. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
[TBL] [Abstract][Full Text] [Related]
19. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
Mangino G; Grazia Capri M; Barnaba V; Alberti S
Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
[TBL] [Abstract][Full Text] [Related]
20. Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: a critical role for costimulation by B7 on both tumor and host antigen-presenting cells.
Maric M; Zheng P; Sarma S; Guo Y; Liu Y
Cancer Res; 1998 Aug; 58(15):3376-84. PubMed ID: 9699669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
